Asiaticoside for Apical Periodontitis Intracanal Infections

This clinical trial aims to assess how well a medication called Asiaticoside works when used inside the root canal of teeth affected by a condition known as apical periodontitis. This condition involves infection and inflammation at the tip of the tooth root, leading to pain and potential tooth loss if untreated. The study compares Asiaticoside to two other common medications, calcium hydroxide and Ledermix, to see which one is better at reducing bacteria and inflammation in the affected teeth. This research is important because finding more effective treatments could improve dental health and outcomes for patients suffering from this painful condition. Participants in the study receive treatment involving the application of the Asiaticoside directly into the root canal of their affected tooth, where it can act on the infection and inflammation. The study evaluates how this treatment impacts the levels of bacteria and inflammatory markers in the tooth and surrounding tissues. By measuring these levels, researchers aim to determine whether Asiaticoside is an effective alternative to current treatments, potentially offering a new way to manage apical periodontitis more effectively.